Cancer Chemotherapy Flashcards

1
Q

What are the four types of traditional agents

A
  • Alkylating agents,
  • Antimetabolites,
  • Cytotoxic antibiotics,
  • Plant derivatives.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the mechanism of alkylating agents?

A

They form covalent bonds with suitable nucleophilic substances (bond to DNA in two positions) in the cell under physiological conditions. This causes intrastand crosslinking of DNA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the alkylating agents groups and name an example?

A

1) Nitrogen mustards eg, Cyclophosphamide.
2) Ethylenimines, eg, Thiotepa.
3) Alkylsulphonates, eg, Busulphan.
4) Hydrazines and Triazines, eg, Temozolomide.
5) Nitrosoureas, eg, Lomustine.
6) Platinum base compounds, eg, Cisplatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name the main groups of antimetabolites and their mechanism?

A

Mimic normal cell metabolites

1) Antifolates, eg, methotrexate.
2) Antipyrimidines, eg, 5-flurouricil,
3) Antipurines, eg, mercaptopurine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name some examples of cytotoxic antibiotics and their mechanism

A

Antitumour antibiotics which produce their effects mainly by direct action on DNA. eg, Anthracyclins (Doxorubicin), dactinomycin, bleomycin and mitomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the mechanism of plant derivates and some examples.

A

Spindle poisons - Either affect microtubule function and prevent mitotic spindle formation or topoisomerase 1/2 inhibitors.

1) Vinca alkaloids, eg, vincristine. (spindle poison)
2) Taxanes, eg, paclitaxcel. (spindle poison)
3) Camptothecins, eg, Irinotecan. (Topoisomerase 1 inhibitor)
4) Etoposide - DNA binding/ topoisomerase 2 binding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the main drawbacks of chemotherapy for cancer?

A
  • Targets cell proliferation rather than the cancer specific features of invasion and metastasis. Healthy cells which have a high rate of growth and multiplication include cells of bone marrow, GI mucosa, hair and skin.
  • Non-specific cell killers.
  • Potential development of resistance.
  • Can leave some cells remaining.
  • Non compliance due to nasty side effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is tumour lysis syndrome and their features?

A
  • It is an acute side effect and a metabolic emergency which occurs due to rapid cell lysis and large amounts of cell metabolites entering the blood.
  • Characterised by hyperuricaemia, hyperphosphataemia and hypocalcaemia. If untreated can lead to acute renal failure, cardiac arrest and death.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the effects of chemotherapy on the bone marrow

A

Myelosuppression - Reduced production of actively dividing cells which provide immunity, oxygen transport and clotting common with many chemotherapy agents.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is used in bone marrow side effects?

A

Recombinant human granulocyte-colony stimulating factors, (eg, filgrastim) to reduce incidence/duration of myelosupression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some of the gastro-intestinal?

A

1) Nausea and vomiting,
2) loss of appetite,
3) Constipation (give laxatives),
4) Diarrhoea (give anti-diarrhoeal eg, loperamide)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe what drugs have varying different emetigenic properties and the treatment

A
  • Highly emetogenic = cisplatin.
  • Moderately emetogenic = doxorubicin.
  • Mildly emetogenic - etoposide.
    Treatment choices’ are between use of benzodiazepine, use of steroids, and anti-emetics.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe some of specific side-effect mucositis.

A

Ulceration, dry mouth, pain and taste alterations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some other side effects?

A
  • Fatigue,
  • Body image side-effects dur to hair loss, weight changes.
  • Peripheral neuropathy,
  • Altered renal function and,
  • Delayed effects such as infertility or secondary malignancy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe and name anticancer drugs

A

Monoclonal antibodies and small molecules such as:

  • Rituximab (Targets B cell surface proteins in B cell lymphomas).
  • Trastuzumab (herceptin) which targets epidermal growth factor receptor 2 and used in breast cancer.
  • Imatinib (Gleevac) inhibits bcr-abl gene signalling pathways and is used in chronic myeloid leukaemia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe features of personalised medicine?

A
  • It should be predictive, personalised, preventative and participatory. This can increase the effectiveness.
17
Q

What are the aims of of personalised medicine in NHS Scotland?

A

1) Improve prevention based on underlying predisposition.
2) Earlier diagnosis of disease as a result of identifying.
3) more precise diagnosis based on cause.
4) Targeted interventions through the use of companion diagnostics to identify and stratify patients for effective treatments.

18
Q

What are some of the drugs for non small cell lung cancer and the mutational profile that needs to be present for their indication?

A

Erlotinib - Activating mutation in EGFR.

No Drug - Activating mutations in KRAS.

Crizotinib - ALK rearrangement.

If patient’s do not have this criteria then they are given some other chemotherapy agent.

19
Q

What are some of the medications for colorectal cancer and their indications

A

Cetuximab (anti-EGFR) monoclonal antibody therapy. Indications - No mutations in KRAS/NRAS so you can use cetuximab plus chemotherapy. If there is mutations present the it predicts lack of response to therapy.

20
Q

What is the most common mutation in melanoma?

A

About 40-60% of melanomas carry mutations which activate a gene called BRAF which leads to further tumour growth.

21
Q

What is the personalised medicine treatment for melanomas?

A

Vermurafenib - Inhibitor of mutated B-Raf.

22
Q

Describe the treatment for high grade glioblastomas (brain tumours)

A

Temozolomide. Having high MGMT promotor gene methylation can indicate the efficacy of the medication might be

23
Q

Describe the personalised medical treatment for gastric tumours

A

Trastuzumab - Anti-Her2 (As well as cisplatin and 5-fluorouracil)

24
Q

What is the function of MGMT?

A

DNA repair enzyme. Methylation of MGMT gene decreases the expression of the MGMT protein and correlates with longer survival.

25
Q

What is the less common treatment for gastric tumours

A

About 3% have C-KIT mutation. If they are C-KIT positive metastatic gastrointestinal stromal tumours then they are given imatinib.

26
Q

What are the ways of accurately diagnosing soft tissue and bone tumours and explain why?

A

FISH analysis for Ewing’s sarcomas, alveolar rhabdomyosarcoma, leiomyosarcomas and fibromyxoid sarcoma. These are normally hard to distinguish from each other

27
Q

What is the analysis used aid in the diagnosis of papillary thyroid tumours?

A

BRAF mutation analysis as BRAF mutation is associated with an aggressive tumour phenotype and higher risk of recurrence of the disease.

28
Q

What is pharmacogenetics

A

The study of the way a patient’s genome affects their response to drugs. This means potentially life-threatening toxicity can be avoided

29
Q

What is Nivolumab?

A

IgG4 PD-1 immune checkpoint inhibitor that disrupts the PD-1 Mediated signalling and restores antitumor immunity. Used in melanoma and NSCLC

30
Q

What is ipilimumab?

A

Anti-CTLA-4 antibody which is used in metastatic melanoma.